B-lynch Transverse Compression Suture

Status Recruiting

Clinical Trial Summary

Is B-Lynch transverse compression suture safe and effective in controlling excessive blood loss during conservative management of women with placenta previa?

Clinical Trial Description

To perform B-Lynch Transverse Compression Suture the investigators will use the suture material 1 Polyglactin 910 with a 70mm ½ circle needle mounted on a 90 cms suture. the investigators will use the needle blunt ended to puncture the uterus 3 cms above the upper margin of the incision posteriorly and behind the vascular bundle. The needle is retrieved through the cavity of the uterus and pulled inferiorly with the suture material lying on the posterior wall of the uterine cavity. The needle then perforates the posterior wall of the uterus 1-3 cms below the inferior margin of the Caesarean incision and exists behind the vascular bundle of the same side of the uterus retrieved and runs on the surface of the lower segment below the incision margin parallel to it and taking a 1 cm bite of tissue for stabilization running to the other side. After encircling the para-uterine vasculature, the needle then perforates the posterior side of the uterus behind the vascular bundle entering the uterine cavity 1-3 cm below the inferior margin of the Caesarean incision. The suture can lie freely on the posterior wall of the uterine cavity and exists 3 cms above the upper margin of the Caesarean incision. It exits posteriorly and behind the vascular bundle to meet the suture from the other side. It is essential that the ureters are identified by palpation or visual observation after the bladder is displaced inferiorly and held by traction. Any observed bleeding should be dealt with in the usual way. At the end of the suture application and before tying the knots, the lower segment is compressed again transversely whilst the suture is held taut to ensure that bleeding has ceased by swabbing the vagina again. A wide pore drain will be inserted in the Douglas pouch, and the abdominal wall will be repaired. ;

Study Design

Related Conditions & MeSH terms

Blood Loss, Surgical

Clinical Trial Details

NCT number	NCT06359886
Study type	Interventional
Source	Alexandria University
Contact	Ahmed S Zeerban, Msc
Phone	+201003119968
Email	Ahmedzeerban@gmail.com
Status	Recruiting
Phase	N/A
Start date	March 20, 2024
Completion date	September 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04114253` - QStat in Liver Transplant
Recruiting	`NCT05077124` - Safe and Timely Antithrombotic Removal (STAR) Registry
Active, not recruiting	`NCT03651154` - Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections	N/A
Recruiting	`NCT04519593` - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma	N/A
Completed	`NCT02043132` - Tranexamic Acid in Reverse Total Shoulder Arthroplasty	Phase 2/Phase 3
Withdrawn	`NCT00861367` - Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate	N/A
Terminated	`NCT03246919` - Ideal Time of Oxytocin Infusion During Cesarean Section	Phase 4
Completed	`NCT04443920` - Tranexamic Acid for Total Knee Arthroscopy	Phase 4
Withdrawn	`NCT04933253` - Mediastinal Temperature and Post-operative Bleeding	N/A
Recruiting	`NCT02938962` - Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)	Phase 4
Recruiting	`NCT02130752` - Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery	N/A
Recruiting	`NCT05164809` - Effect of Electrosurgery on Blood Loss and Intraoperative Transfusions in Musculoskeletal Tumor Surgery
Not yet recruiting	`NCT04574128` - Retransfusion or Not of Cardiotomy Blood	N/A
Completed	`NCT02911831` - IV Tranexamic Acid Prior to Hysterectomy	Early Phase 1
Completed	`NCT02740374` - Evaluation of Thromboelastometry (ROTEM) During Spinal Surgery	N/A
Enrolling by invitation	`NCT05474027` - Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery	Phase 4
Completed	`NCT05391607` - Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement	Phase 4
Completed	`NCT03152461` - Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
Recruiting	`NCT02441751` - Intraoperative Volume Management and QT Interval
Completed	`NCT01053169` - Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.